Harvard Heart Letter

The new strategy for statins: Should you be taking one?

New guidelines for prescribing the cholesterol-lowering drugs known as statins no longer focus on an individual's starting blood cholesterol value. Instead, the decision should focus on an individual's overall risk of heart disease.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In